| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83032-001-02 | 83032-001 | HUMAN PRESCRIPTION DRUG | Regadenoson | Regadenoson | INJECTION, SOLUTION | INTRAVENOUS | 20240822 | N/A | ANDA | ANDA218054 | Indies Pharma Jamaica Limited | REGADENOSON | .08 mg/mL | 1 SYRINGE in 1 CARTON (83032-001-02) / 5 mL in 1 SYRINGE |
| 85742-012-09 | 85742-012 | HUMAN PRESCRIPTION DRUG | Regadenoson | Regadenoson | INJECTION, SOLUTION | INTRAVENOUS | 20240822 | N/A | ANDA | ANDA218054 | Kanchan Healthcare Inc | REGADENOSON | .08 mg/mL | 1 SYRINGE in 1 CARTON (85742-012-09) / 5 mL in 1 SYRINGE |
| 10135-803-51 | 10135-803 | HUMAN PRESCRIPTION DRUG | Regadenoson | Regadenoson | INJECTION, SOLUTION | INTRAVENOUS | 20240822 | N/A | ANDA | ANDA218054 | Marlex Pharmaceuticals, Inc. | REGADENOSON | .08 mg/mL | 1 SYRINGE in 1 CARTON (10135-803-51) / 5 mL in 1 SYRINGE |